Publicaciones en las que colabora con MARÍA DEL CARMEN MORENO RUIZ (47)

2024

  1. Psychopharmacology in children and adolescents: unmet needs and opportunities

    The Lancet Psychiatry, Vol. 11, Núm. 2, pp. 143-154

2023

  1. Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study

    Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280

  2. Oxytocin Exposure in Labor and its Relationship with Cognitive Impairment and the Genetic Architecture of Autism

    Journal of Autism and Developmental Disorders, Vol. 53, Núm. 1, pp. 66-79

  3. Systematic Review and Meta-analysis: Efficacy of Pharmacological Interventions for Irritability and Emotional Dysregulation in Autism Spectrum Disorder and Predictors of Response

    Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 62, Núm. 2, pp. 151-168

  4. The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications

    Neuroscience and Biobehavioral Reviews, Vol. 149

  5. The impact of COVID-19 lockdown on child and adolescent mental health: systematic review

    European Child and Adolescent Psychiatry, Vol. 32, Núm. 7, pp. 1151-1177

  6. The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study

    Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 10, pp. 1573-1580

2022

  1. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

2021

  1. Patient care, right to information and consent for minors in situations of parental conflict. Clinical guidelines in the context of Spanish legislation

    Anales de Pediatria, Vol. 94, Núm. 5, pp. 338.e1-338.e7

  2. Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders

    JAMA Psychiatry, Vol. 78, Núm. 1, pp. 47-63

2020

  1. Episignatures Stratifying Helsmoortel-Van Der Aa Syndrome Show Modest Correlation with Phenotype

    American Journal of Human Genetics, Vol. 107, Núm. 3, pp. 555-563

  2. Premorbid Adjustment and IQ in Patients with First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship with Cannabis Use

    Schizophrenia Bulletin, Vol. 46, Núm. 3, pp. 517-529

  3. The Positive and Negative Syndrome Scale for Schizophrenia Autism Severity Scale (PAUSS) in young people with autism and schizophrenia

    Revista de Psiquiatria y Salud Mental, Vol. 13, Núm. 3, pp. 118-130

2019

  1. Dietary Interventions for Autism Spectrum Disorder: A Meta-analysis

    Pediatrics, Vol. 144, Núm. 5

  2. Differences in the regulation of inflammatory pathways in adolescent- and adult-onset first-episode psychosis

    European Child and Adolescent Psychiatry, Vol. 28, Núm. 10, pp. 1395-1405

  3. Functional gastrointestinal disease in autism spectrum disorder: A retrospective descriptive study in a clinical sample

    Frontiers in Psychiatry, Vol. 10

  4. Neuroanatomical deficits shared by youth with autism spectrum disorders and psychotic disorders

    Human Brain Mapping, Vol. 40, Núm. 5, pp. 1643-1653

2018

  1. Gray matter changes and cognitive predictors of 2-year follow-up abnormalities in early-onset first-episode psychosis

    European Child and Adolescent Psychiatry, Vol. 27, Núm. 1, pp. 113-126

  2. The complex association between the antioxidant defense system and clinical status in early psychosis

    PLoS ONE, Vol. 13, Núm. 4

2017

  1. Atypical age-dependency of executive function and white matter microstructure in children and adolescents with autism spectrum disorders

    European Child and Adolescent Psychiatry, Vol. 26, Núm. 11, pp. 1361-1376